Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1CNS 1

Conditions

Hodgkin Disease 37Melanoma 22Lymphoma 8Sarcoma 6Neoplasm Metastasis 5Leiomyosarcoma 3Uveal Melanoma 2Skin Neoplasms 2Sarcoma, Synovial 2Neoplasms 2Thyroid Neoplasms 1Solitary Fibrous Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Parathyroid Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Immunotherapy 1Hyperthermia 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangioendothelioma, Epithelioid 1Hemangioendothelioma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1

Interventions

Magnetic Resonance Spectroscopy 6Temozolomide 4Radiotherapy 4Biopsy 3sargramostim 2Imatinib Mesylate 2Donepezil 2Carboplatin 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2temsirolimus 1gallium Ga 68 dotatate 1fluorodopa F 18 1aldesleukin 1Vinblastine 1Topotecan 1Thalidomide 1Tamoxifen 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Reverse Transcriptase Polymerase Chain Reaction 1Radiation 1Photochemotherapy 1Pharmacogenomic Testing 1O(6)-benzylguanine 1Muromonab-CD3 1Modafinil 1Methylphenidate 1Mental Status and Dementia Tests 1Lapatinib 1Introns 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Glioma, Subependymal × Dacarbazine × Clear all
NCT00498979 2020-07-24

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Case Comprehensive Cancer Center

Phase 1 Completed
22 enrolled
CNSDermatologicSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Melanoma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡